AMDX-2011P

· Amydis Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AMDX-2011P, covering 2024-07-30 to 2026-02-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AMDX-2011P in Participants With Alzheimer's Disease [Phase 2]